A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance.

Authors

Jacqueline Olender, George Washington University
Bi-Dar Wang
Travers Ching
Lana X Garmire
Kaitlin Garofano, George Washington University
Youngmi Ji
Tessa Knox, George Washington University
Patricia Latham
Kenneth Nguyen, George Washington University
Johng Rhim
Norman H. Lee, George Washington University

Document Type

Journal Article

Publication Date

10-1-2019

Journal

Molecular cancer research : MCR

Volume

17

Issue

10

Inclusive Pages

2115-2125

DOI

10.1158/1541-7786.MCR-19-0415

Comments

Epub 2019 Jul 2.

APA Citation

Olender, J., Wang, B., Ching, T., Garmire, L., Garofano, K., Ji, Y., Knox, T., Latham, P., Nguyen, K., Rhim, J., & Lee, N. H. (2019). A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance.. Molecular cancer research : MCR, 17 (10). http://dx.doi.org/10.1158/1541-7786.MCR-19-0415

Peer Reviewed

1